Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

about

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Item

http://www.wikidata.org/entity/Q47652358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can suitable candidates for le ...... tified using current evidence?

@en

Can suitable candidates for le ...... tified using current evidence?

@nl

type

Item

label

Can suitable candidates for le ...... tified using current evidence?

@en

Can suitable candidates for le ...... tified using current evidence?

@nl

prefLabel

Can suitable candidates for le ...... tified using current evidence?

@en

Can suitable candidates for le ...... tified using current evidence?

@nl

P1476

Can suitable candidates for le ...... tified using current evidence?

@en

P2093

Adolfo Mínguez-Castellanos

http://www.w3.org/2001/XMLSchema#string

José Manuel García-Moreno

http://www.w3.org/2001/XMLSchema#string

Maria José Catalán

http://www.w3.org/2001/XMLSchema#string

Matilde Calopa

http://www.w3.org/2001/XMLSchema#string

Oriol de Fábregues

http://www.w3.org/2001/XMLSchema#string

Ovidiu Băjenaru

http://www.w3.org/2001/XMLSchema#string

Stephen W Pedersen

http://www.w3.org/2001/XMLSchema#string

Zvezdan Pirtošek

http://www.w3.org/2001/XMLSchema#string

P2860

The natural history of Parkinson’s disease

Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches.

Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease

Parkinson's disease

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

Continuous drug delivery in Parkinson's disease.

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

P304

44-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.ENSCI.2017.06.004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Angelo Antonini

Jaime Kulisevsky

Per Odin

P577

2017-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29260038

http://www.w3.org/2001/XMLSchema#string

P921

levodopa

P932

5730910

http://www.w3.org/2001/XMLSchema#string